A 23-year-old woman, negative for anti-human immunodeficiency virus, was admitted to our hospital with a 15-day history of fever, cough, headache, and convulsion. Physical examination was normal except for left side hypoesthesia. Laboratory findings were within normal range except for C-reactive protein (63 mg/L) and erythrocyte sedimentation rate (52 mm/h). A miliary pattern was detected by high-resolution computed tomography scanning (Fig. 1). Fundoscopic examination revealed bilateral choroid tubercles (Fig. 2). Since multiple intracranial tuberculomas were detected by cranial magnetic resonance imaging (MRI) (Fig. 3), isoniazid, rifampicin, ethambutol, pyrazinamide, and dexamethasone were administered, and antiepileptic therapy was started. Her symptoms disappeared on day 10. Deterioration in the patient’s condition, based on clinical and radiological tests, on month 1, 2, and 4 was considered to be a recurrent paradoxical reaction (PR). The patient was treated with prolonged high-dose steroid therapy and with the same antituberculosis therapeutic regimen. The intracranial nodules disappeared by month 7 (Fig. 4).
WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.